![Brent Pfeiffenberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brent Pfeiffenberger
Directeur Général chez
CENTURY THERAPEUTICS, INC.
Fortune : 9 M $ au 31/05/2026
Profil
Brent Pfeiffenberger is currently Chairman, President & Chief Executive Officer at Century Therapeutics, Inc. starting in 2025 and Independent Director at Corbus Pharmaceuticals Holdings, Inc. starting in 2026.
Former roles include Chief Operating Officer at Neogene Therapeutics, Inc. from 2021 to 2023 and Director at Medicines Australia.
Education includes an MBA from The Wharton School of the University of Pennsylvania and a doctorate from Duquesne University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 3 665 474 ( 2,03% ) | 9 M $ | 31/05/2026 |
Postes actifs de Brent Pfeiffenberger
| Sociétés | Poste | Début |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Directeur Général | 04/12/2023 |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 13/05/2026 |
Anciens postes connus de Brent Pfeiffenberger
| Sociétés | Poste | Fin |
|---|---|---|
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Directeur des opérations | 01/12/2023 |
Medicines Australia
 Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Directeur/Membre du Conseil | - |
Formation de Brent Pfeiffenberger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Neogene Therapeutics, Inc.
Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
